Process validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process is capable of consistently delivering quality products.
Process validation is a requirement of current Good Manufacturing Practices (GMPs) for finished pharmaceuticals (21CFR 211) and of the GMP regulations for medical devices (21 CFR 820) and therefore applies to the manufacture of both drug products and medical devices.
Process validation involves a series of activities taking place over the lifecycle of the product and process.
The U.S. Food and Drug Administration (FDA) has proposed guidelines with the following definition for process validation: – “PROCESS VALIDATION” is establishing documented evidence which provides a high degree of assurance that a specific process consistently produces a product meeting its predetermined specifications and quality attributes.
The process validation activities can be described in three stages.
Stage 1 – Process Design: The commercial process is defined during this stage based on knowledge gained through development and scale-up activities.
Stage 2 – Process Qualification: During this stage, the process design is confirmed as being capable of reproducible commercial manufacturing.
Stage 3 – Continued Process Verification: Ongoing assurance is gained during routine production that the process remains in a state of control.
Process validation is the bedrock of good manufacturing practice, it’s also the first step to realizing significant time and cost savings in validation. Make sure you’re in position to succeed and drive excellence in your organization by watching our webinar, AI & process validation.
Types of process validation
The guidelines on general principles of process validation mentions four types of validation:
- A) Prospective validation (or premarket validation)
- B) Retrospective validation
- C) Concurrent validation
- D) Revalidation
A) Prospective validation (or premarket validation)
Establishing documented evidence prior to process implementation that a system does what it proposed to do based on preplanned protocols. This approach to validation is normally undertaken whenever the process for a new formula (or within a new facility) must be validated before routine pharmaceutical production commences. In fact, validation of a process by this approach often leads to transfer of the manufacturing process from the development function to production.
B) Retrospective validation
Retrospective validation is used for facilities, processes, and process controls in operation use that have not undergone a formally documented validation process. This approach is particularly relevant in facilities and utilities validation where historical operational data can demonstrate compliance and effectiveness. Therefore, this type of validation is only acceptable for well-established processes and will be inappropriate where there have been recent changes in the composition of product, operating processes, or equipment.
This approach is rarely used today because it’s very unlikely that any existing product hasn’t been subjected to the Prospective validation process. It is used only for the audit of a validated process.
C) Concurrent validation
Concurrent validation is used for establishing documented evidence that a facility and processes do what they purport to do, based on information generated during actual imputation of the process. This approach involves monitoring of critical processing steps and end product testing of current production, to show that the manufacturing process is in a state of control.
D) Revalidation
Revalidation means repeating the original validation effort or any part of it, and includes investigative review of existing performance data. This approach is essential to maintain the validated status of the plant, equipment, manufacturing processes and computer systems. Possible reasons for starting the revalidation process include:
- The transfer of a product from one plant to another.
- Changes to the product, the plant, the manufacturing process, the cleaning process, or other changes that could affect product quality.
- The necessity of periodic checking of the validation results.
- Significant (usually order of magnitude) increase or decrease in batch size.
- Sequential batches that fail to meet product and process specifications.
- The scope of revalidation procedures depends on the extent of the changes and the effect upon the product.
FAQ
What are the four types of process validation?
The four types of process validation used in pharmaceutical and life sciences manufacturing are prospective validation, retrospective validation, concurrent validation, and revalidation. Each approach is used at different stages of a product’s lifecycle to demonstrate that a manufacturing process consistently produces products meeting predetermined quality specifications.
- Prospective validation establishes documented evidence before commercial production begins.
- Concurrent validation evaluates process performance during routine manufacturing.
- Retrospective validation uses historical production data from well-established processes.
- Revalidation confirms that validated processes remain in control after changes to equipment, processes, or operating conditions.
Together, these validation approaches help manufacturers ensure regulatory compliance, maintain product quality, and demonstrate process control throughout the product lifecycle.
What is prospective process validation?
Prospective validation is a type of process validation performed before routine commercial manufacturing begins. It establishes documented evidence that a process can consistently produce products meeting predefined quality specifications.
During prospective validation, manufacturers develop validation protocols, identify critical process parameters, and conduct controlled testing to demonstrate that the manufacturing process performs reliably under defined operating conditions.
Prospective validation is commonly used when introducing new pharmaceutical products, manufacturing processes, or facilities, ensuring that production systems are validated before large-scale manufacturing starts.
What is concurrent process validation?
Concurrent validation is a type of process validation conducted during actual commercial manufacturing while the product is being produced for distribution.
In concurrent validation, manufacturers collect and analyze process data in real time while monitoring critical process parameters and product quality attributes. This approach demonstrates that the manufacturing process remains in a state of control under normal production conditions.
Concurrent validation may be used when limited production data is available or when manufacturing must begin before full validation studies can be completed. However, strict monitoring and documentation are required to ensure compliance with regulatory expectations.
When should retrospective validation be used?
Retrospective validation evaluates historical production data to demonstrate that a manufacturing process has consistently produced compliant products over time.
This type of process validation is applied to well-established processes that were previously operated without formal validation protocols. Manufacturers analyze existing batch records, testing data, and production history to confirm that the process consistently met quality specifications.
Retrospective validation is rarely used in modern pharmaceutical manufacturing because most regulatory frameworks now require prospective validation before commercial production begins.
What triggers the need for revalidation in pharmaceutical manufacturing?
Revalidation is required when changes occur that could affect the performance or reliability of a validated manufacturing process.
Common triggers for revalidation include:
- Changes to product formulation or raw materials
- Modifications to manufacturing equipment or facilities
- Process parameter adjustments
- Technology transfers between manufacturing sites
- Significant changes in batch size or production scale
- Repeated deviations or out-of-specification results
Revalidation ensures that the manufacturing process remains capable of consistently producing products that meet regulatory and quality requirements.
What is the difference between the three stages and four types of process validation?
The three stages of process validation describe the lifecycle framework defined by the FDA, while the four types of process validation describe different validation approaches used within that lifecycle.
The three stages of process validation are:
- Process Design — development studies establish the manufacturing process and identify critical process parameters.
- Process Qualification — equipment and manufacturing processes are qualified to confirm they operate as intended.
- Continued Process Verification — ongoing monitoring ensures the process remains in a validated state during commercial production.
The four types of process validation — prospective, concurrent, retrospective, and revalidation — describe how manufacturers establish validation evidence at different points in this lifecycle.
How do prospective and concurrent validation differ?
The difference between prospective validation and concurrent validation lies in when validation evidence is collected.
Prospective validation occurs before routine manufacturing begins. Validation studies are executed using predefined protocols to demonstrate that the process can consistently produce compliant products before commercial production starts.
Concurrent validation, by contrast, occurs during actual manufacturing operations. Data is collected while products are being produced for distribution, allowing manufacturers to evaluate process performance in real time.
Prospective validation is the most commonly used approach for new pharmaceutical processes, while concurrent validation may be applied when production must begin before full validation studies are completed.
Why is process validation important in pharmaceutical manufacturing?
Process validation is essential because it provides documented evidence that pharmaceutical manufacturing processes consistently produce products meeting predetermined quality standards.
Without validated processes, manufacturers cannot reliably ensure product safety, efficacy, or regulatory compliance. Validation activities help organizations identify critical process parameters, control sources of variability, and maintain consistent product quality across production batches.
Regulatory agencies such as the FDA and EMA require process validation as part of current Good Manufacturing Practices (cGMP) to ensure that pharmaceutical products are safe and effective for patients.
How can digital validation software support process validation?
Digital validation platforms help life sciences organizations streamline process validation activities by replacing manual documentation and fragmented workflows with centralized digital systems.
With digital validation software, teams can author validation protocols, execute testing electronically, manage deviations, and maintain traceable documentation across validation studies. This improves collaboration between quality, engineering, and manufacturing teams while supporting data integrity requirements such as ALCOA+.
By digitizing process validation workflows, organizations can reduce validation cycle times, improve documentation quality, and gain real-time visibility into validation progress across manufacturing sites.
Talk to an Expert
Kneat supports any of your validation needs with a purpose-built platform that digitizes the entire validation life cycle for greater speed and accuracy, improved transparency, and guaranteed data integrity compliance.
We’ve reduced cycle times by over 40% for eight of the world’s top ten pharmaceutical companies. See how you can experience the same value
